Cognitive Function in Adults With Cardiac Disease

NCT ID: NCT01043315

Last Updated: 2022-04-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

66 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-07-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to identify cardiac patients' degree of unappreciated mild impairment in cognitive function patterns of cognitive function, and influencing factors related to cognitive functioning during hospitalization. The results from the study will contribute to tailoring the delivery of patient education to optimize patient understanding of information in future clinical practice.

It is hypothesized that the study will demonstrate the following:

1. The degree of cognitive function for patients hospitalized in a CICU will be below the scores for normal functioning adults.
2. Patients with acute cardiovascular conditions will score differently in cognitive functioning at various times throughout their hospitalization.
3. Relationships between cognitive function and following variables:

* Patients with greater sleep deprivation or fatigue will exhibit lower cognitive functioning.
* Patients with greater hunger will exhibit lower cognitive functioning.
* Patients who are experiencing greater anxiety will exhibit lower cognitive functioning.
* Patients who are experiencing depression will exhibit lower cognitive functioning.
* Patients who have undergone or will undergo shortly treatment or procedures will exhibit lower cognitive functioning.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cognitive Impairment Cardiac Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hospitalized Cardiac Patient

Adults admitted to Coronary intensive unit being treated for acute cardiovascular conditions

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Admission to the Cardiac Intensive Care Unite for acute cardiological issues during time of enrollment.
* Patients with NYHA class I, II, III, and IV.
* 18 years or older and must be awake and conversant at time of enrollment.

Exclusion Criteria

* History of neurological disorder or injury (e.g., Alzheimer's Disease, dementia, stroke, seizures).
* Moderate or severe head injury (defined as \> 24 hours loss of consciousness)
* Past or current history of severe psychiatric illness. Specifically, psychotic disorders (e.g., schizophrenia) and bipolar disorder. Potential participants will not be excluded on the basis of managed depression or anxiety disorder. These conditions are common in cardiac patients and their exclusion may limit the generalizability of findings.
* 5 years past or current history of alcohol or drug abuse (defined by DSM-IV criteria).
* History of learning disorder or developmental disability (defined by DSM-IV criteria).
* Renal failure requiring dialysis.
* History of sleep apnea (defined through previous sleep studies).
* Severely ill individuals, including those who are sedated, on a ventilator, exhibiting acute hemodynamic changes, and/or those deemed inappropriate by patient's physician to participate in study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospitals Cleveland Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Richard Josephson, MS MD

Professor of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Richard Josephson, MS, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospitals Cleveland Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospitals of Cleveland

Cleveland, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

05-09-25

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.